NO305164B1 - Aminosyresubstituerte benzoylguanidiner, deres anvendelse til fremstilling av medikament eller diagnostikum samt medikamenter inneholdende dem - Google Patents
Aminosyresubstituerte benzoylguanidiner, deres anvendelse til fremstilling av medikament eller diagnostikum samt medikamenter inneholdende demInfo
- Publication number
- NO305164B1 NO305164B1 NO953553A NO953553A NO305164B1 NO 305164 B1 NO305164 B1 NO 305164B1 NO 953553 A NO953553 A NO 953553A NO 953553 A NO953553 A NO 953553A NO 305164 B1 NO305164 B1 NO 305164B1
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- opt
- drugs
- substd
- ome
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Surgery (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4432101A DE4432101A1 (de) | 1994-09-09 | 1994-09-09 | Aminosäure-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (3)
Publication Number | Publication Date |
---|---|
NO953553D0 NO953553D0 (no) | 1995-09-08 |
NO953553L NO953553L (no) | 1996-03-11 |
NO305164B1 true NO305164B1 (no) | 1999-04-12 |
Family
ID=6527786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO953553A NO305164B1 (no) | 1994-09-09 | 1995-09-08 | Aminosyresubstituerte benzoylguanidiner, deres anvendelse til fremstilling av medikament eller diagnostikum samt medikamenter inneholdende dem |
Country Status (23)
Country | Link |
---|---|
US (1) | US5631293A (fr) |
EP (1) | EP0700899B1 (fr) |
JP (1) | JP3828597B2 (fr) |
KR (1) | KR960010618A (fr) |
CN (1) | CN1057760C (fr) |
AT (1) | ATE178315T1 (fr) |
AU (1) | AU695234B2 (fr) |
CA (1) | CA2157859C (fr) |
CZ (1) | CZ289760B6 (fr) |
DE (2) | DE4432101A1 (fr) |
DK (1) | DK0700899T3 (fr) |
ES (1) | ES2131241T3 (fr) |
FI (1) | FI954192A (fr) |
GR (1) | GR3030365T3 (fr) |
HU (1) | HU220762B1 (fr) |
IL (1) | IL115195A (fr) |
NO (1) | NO305164B1 (fr) |
NZ (1) | NZ272947A (fr) |
PL (1) | PL180244B1 (fr) |
RU (1) | RU2154055C2 (fr) |
SI (1) | SI9500282B (fr) |
TW (1) | TW419455B (fr) |
ZA (1) | ZA957550B (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4412334A1 (de) * | 1994-04-11 | 1995-10-19 | Hoechst Ag | Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
EP0765867A1 (fr) * | 1995-09-27 | 1997-04-02 | Hoechst Aktiengesellschaft | Benzoylguanidines substituées, procédé de leur préparation, leur utilisation comme agent antiarythmique ou diagnostique ainsi que le médicament les contenant |
DE19540995A1 (de) * | 1995-11-03 | 1997-05-07 | Hoechst Ag | Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19542306A1 (de) * | 1995-11-14 | 1997-05-15 | Hoechst Ag | Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
PL316439A1 (en) * | 1995-11-20 | 1997-05-26 | Hoechst Ag | Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such |
DE19546736A1 (de) * | 1995-12-14 | 1997-06-19 | Hoechst Ag | Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate |
DE19621319A1 (de) * | 1996-05-28 | 1997-12-04 | Hoechst Ag | Bis-ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
US6852739B1 (en) * | 1999-02-26 | 2005-02-08 | Nitromed Inc. | Methods using proton pump inhibitors and nitric oxide donors |
DE10059418A1 (de) * | 2000-11-30 | 2002-06-20 | Aventis Pharma Gmbh | Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
WO2004012659A2 (fr) * | 2002-08-01 | 2004-02-12 | Nitromed, Inc. | Inhibiteurs nitroses de la pompe a protons, compositions et procedes d'utilisation |
US6794401B2 (en) * | 2003-01-17 | 2004-09-21 | Bexel Pharmaceuticals, Inc. | Amino acid phenoxy ethers |
DE10338554A1 (de) * | 2003-08-22 | 2005-03-31 | Aventis Pharma Deutschland Gmbh | Pentafluorosulfanylphenyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
EP2486910A3 (fr) | 2006-10-27 | 2012-08-22 | The Curators Of The University Of Missouri | Appareil comprenant plusieurs chambres et une tête de distribution |
US20080194307A1 (en) * | 2007-02-13 | 2008-08-14 | Jeff Sanger | Sports-based game of chance |
US8247440B2 (en) | 2008-02-20 | 2012-08-21 | Curators Of The University Of Missouri | Composition comprising omeprazole, lansoprazole and at least one buffering agent |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3780027A (en) | 1970-04-29 | 1973-12-18 | Merck & Co Inc | Anthranilic acid derivatives |
DE3502629A1 (de) * | 1985-01-26 | 1986-07-31 | Hoechst Ag, 6230 Frankfurt | Phenoxybenzoesaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung im pflanzenschutz |
DE3929582A1 (de) | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
CZ284456B6 (cs) * | 1992-02-15 | 1998-12-16 | Hoechst Aktiengesellschaft | Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje |
EP0556674B1 (fr) * | 1992-02-15 | 1996-06-19 | Hoechst Aktiengesellschaft | Benzoylguanidines 3,5-substitués avec une activité antiarrhythmique et une activité inhibitrice de la prolifération des cellules |
ES2092729T3 (es) * | 1992-07-01 | 1996-12-01 | Hoechst Ag | Benzoilguanidinas 3,4,5-sustituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene. |
ATE147375T1 (de) * | 1992-09-22 | 1997-01-15 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, sowie ihre verwendung als antiarrhythmika |
DE4318658A1 (de) * | 1993-06-04 | 1994-12-08 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1994
- 1994-09-09 DE DE4432101A patent/DE4432101A1/de not_active Withdrawn
- 1994-12-21 TW TW083111975A patent/TW419455B/zh not_active IP Right Cessation
-
1995
- 1995-09-04 ES ES95113847T patent/ES2131241T3/es not_active Expired - Lifetime
- 1995-09-04 AT AT95113847T patent/ATE178315T1/de not_active IP Right Cessation
- 1995-09-04 EP EP95113847A patent/EP0700899B1/fr not_active Expired - Lifetime
- 1995-09-04 DK DK95113847T patent/DK0700899T3/da active
- 1995-09-04 DE DE59505487T patent/DE59505487D1/de not_active Expired - Lifetime
- 1995-09-06 CN CN95116261A patent/CN1057760C/zh not_active Expired - Fee Related
- 1995-09-06 IL IL11519595A patent/IL115195A/en active IP Right Grant
- 1995-09-07 AU AU30506/95A patent/AU695234B2/en not_active Ceased
- 1995-09-07 KR KR1019950029356A patent/KR960010618A/ko not_active Application Discontinuation
- 1995-09-07 NZ NZ272947A patent/NZ272947A/en unknown
- 1995-09-07 RU RU95115524/04A patent/RU2154055C2/ru not_active IP Right Cessation
- 1995-09-07 FI FI954192A patent/FI954192A/fi unknown
- 1995-09-08 JP JP23096895A patent/JP3828597B2/ja not_active Expired - Fee Related
- 1995-09-08 PL PL95310343A patent/PL180244B1/pl unknown
- 1995-09-08 CA CA002157859A patent/CA2157859C/fr not_active Expired - Fee Related
- 1995-09-08 SI SI9500282A patent/SI9500282B/sl unknown
- 1995-09-08 US US08/525,204 patent/US5631293A/en not_active Expired - Lifetime
- 1995-09-08 NO NO953553A patent/NO305164B1/no unknown
- 1995-09-08 ZA ZA957550A patent/ZA957550B/xx unknown
- 1995-09-08 CZ CZ19952317A patent/CZ289760B6/cs not_active IP Right Cessation
- 1995-09-08 HU HU9502632A patent/HU220762B1/hu not_active IP Right Cessation
-
1999
- 1999-05-28 GR GR990401456T patent/GR3030365T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO305164B1 (no) | Aminosyresubstituerte benzoylguanidiner, deres anvendelse til fremstilling av medikament eller diagnostikum samt medikamenter inneholdende dem | |
IL119552A (en) | Substituted sulfonimidamides process for their preparation and pharmaceutical or diagnostic compositions comprising them | |
TR199600319A2 (tr) | Heteroatom-ihtiva-eden benzosiklopentanoksazolidinonlar. | |
GR3036942T3 (en) | Fungicidal fused bicyclic pyrimidinones | |
AU6410780A (en) | Triazine derivatives used as light stabilisers for organic polymers | |
PL310346A1 (en) | Heterocyclic n-oxides substituted benzoyl guanidines, method of obtaining them and therapeutic agents containing such compounds | |
ATE168106T1 (de) | Isoxazoline derivate anwendbar als fibrinogen rezeptor antagonisten | |
HUT42287A (en) | Fungicides containing as active substance morfolinioalcane carbonic acid amid salts and process for production of the active substance | |
ATE116522T1 (de) | Verwendung von 2-n-alkyl-1,2-benzisothiazolin-3- onen als technische mikrobiozide. | |
ATE76408T1 (de) | Carbapenem-antibiotika, ein verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
HU9502633D0 (en) | Bezoyl-guanidine derivatives substituted with fluoroalkyl- or -alkenyl-groups process for producing them, their use as diagnostica or pharmaceuticals, and pharmaceutical compositions containing them | |
ATE33742T1 (de) | Verwendung von 3-amino-1,2-benzisothiazolen als mikrobizide zum schutz technischer materialien. | |
HU914083D0 (en) | Process for producing gramine derivatives | |
Boyle et al. | (4S, 8S)-4, 8-bis (diphenylmethyl)-1, 5, 7-triazabicyclo [4, 4, 0] dec-5-ene; a hindered, chiral, bicyclic guanidine base with effective C2-symmetry | |
CS262989A2 (en) | Method of new substituted 2,4-diamino-5-cyanopyrimidines production |